Nuo Therapeutics (AURX) director nets 396 shares in option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nuo Therapeutics director C. Eric Winzer reported routine equity compensation transactions. On June 30, he exercised stock options for 40,000 shares of common stock at $1.00 per share. The issuer withheld 39,604 shares at the closing price of $1.01 to cover the exercise cost, leaving him with 396 newly issued shares.
Following these transactions, Winzer directly held 212,654 shares of common stock. He also received a new option grant on June 29 for 30,000 shares of common stock at an exercise price of $1.01 per share, vesting fully by June 30, 2027 and expiring on June 29, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
40,000 shares exercised/converted
Mixed
4 txns
Insider
WINZER C ERIC
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to purchase common stock | 40,000 | $0.00 | -- |
| Exercise | Common Stock | 40,000 | $1.00 | $40K |
| Tax Withholding | Common Stock | 39,604 | $1.01 | $40K |
| Grant/Award | Option to purchase common stock | 30,000 | $0.00 | -- |
Holdings After Transaction:
Option to purchase common stock — 0 shares (Direct, null);
Common Stock — 212,654 shares (Direct, null)
Footnotes (1)
- Represents a net exercise of outstanding stock options. The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock. The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01. 15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017. The options fully vest as of June 30, 2027.
Key Figures
Options exercised: 40,000 shares
Shares withheld: 39,604 shares
Net shares received: 396 shares
+5 more
8 metrics
Options exercised
40,000 shares
Common stock options exercised on June 30, 2026 at $1.00
Shares withheld
39,604 shares
Withheld to pay exercise price using $1.01 closing price
Net shares received
396 shares
Net common shares from 40,000-share option exercise
Shares held after transaction
212,654 shares
Director’s direct common stock holdings after June 30, 2026
New option grant size
30,000 options
Options to purchase common stock granted June 29, 2026
New option exercise price
$1.01 per share
Exercise price for 30,000-share option grant
New option vesting date
June 30, 2027
Options fully vest as of this date
New option expiration
June 29, 2036
Expiration date for 30,000-share option grant
Key Terms
net exercise, tax-withholding disposition, Option to purchase common stock, exercise price, +1 more
5 terms
net exercise financial
"Represents a net exercise of outstanding stock options."
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Option to purchase common stock financial
"Option to purchase common stock"
exercise price financial
"The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant, award, or other acquisition financial
"Grant, award, or other acquisition"
FAQ
What insider transactions did Nuo Therapeutics (AURX) director C. Eric Winzer report?
Director C. Eric Winzer reported exercising options for 40,000 Nuo Therapeutics shares and a related tax-withholding disposition. He also reported receiving a new option grant for 30,000 shares, reflecting routine equity compensation activity rather than open-market buying or selling.
What are the key terms of the new stock options granted to the Nuo Therapeutics (AURX) director?
Winzer received options for 30,000 Nuo Therapeutics shares with a $1.01 exercise price. These options vest fully by June 30, 2027 and expire on June 29, 2036, providing long-dated, time-vested equity compensation rather than immediate share ownership.